6.60
Capsovision Inc stock is traded at $6.60, with a volume of 93,781.
It is down -0.60% in the last 24 hours and up +3.45% over the past month.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
See More
Previous Close:
$6.64
Open:
$6.69
24h Volume:
93,781
Relative Volume:
0.96
Market Cap:
$351.19M
Revenue:
$13.56M
Net Income/Loss:
$-26.97M
P/E Ratio:
-11.49
EPS:
-0.5742
Net Cash Flow:
$-24.04M
1W Performance:
-0.30%
1M Performance:
+3.45%
6M Performance:
+10.55%
1Y Performance:
+40.13%
Capsovision Inc Stock (CV) Company Profile
Name
Capsovision Inc
Sector
Industry
Phone
(408) 370-4790
Address
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CV
Capsovision Inc
|
6.60 | 351.19M | 13.56M | -26.97M | -24.04M | -0.5742 |
|
ABT
Abbott Laboratories
|
104.59 | 180.98B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
95.30 | 121.90B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
291.61 | 111.85B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.80 | 63.48B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.65 | 49.95B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-26 | Resumed | Roth Capital | Buy |
| Jul-28-25 | Initiated | Roth Capital | Buy |
| Jul-28-25 | Initiated | The Benchmark Company | Speculative Buy |
Capsovision Inc Stock (CV) Latest News
Wednesday’s insider activity: Major buys at CapsoVision and sells at Diamondback - Investing.com
Form 4 CapsoVision Inc For: 23 September By Investing.com - Investing.com India
Form 4 CapsoVision Inc For: 23 September By Investing.com - Investing.com Canada
Form 4 CapsoVision Inc For: 23 September By Investing.com - Investing.com UK
CapsoVision director Eliyahou Harari buys $10 million in shares By Investing.com - Investing.com Australia
BRIEF-Capsovision Offers 3.2 Million Shares For About $18.0 Million Gross Proceeds - Bitget
CapsoVision Announces $18 Million Direct Stock Offering - TipRanks
Three existing investors agree to buy $18M in new CapsoVision (NASDAQ: CV) shares - Stock Titan
David S. Shields is Named to CapsoVision’s Board - Medical Product Outsourcing
CapsoVision Announces Upcoming Investor Conference Participation for September 2026 - Quiver Quantitative
CapsoVision to Participate in Upcoming Investor Conferences - GlobeNewswire
CapsoVision (CV) Price: Ends Up by 1.86% at $6.02 in the Current Update; Levels: Support at $5.72 and Resistance at $6.32 Frame the Range in the Available RecordSize Factor - vinanet.vn
CapsoVision (CV) Price: Ends Up by 1.86% at $6.02 in the Current Update; Levels: Support at $5.72 and Resistance at $6.32 Frame the Range in the Available RecordAAII Bullish - dars.gov.et
CapsoVision (CV) Levels: Rises 1.86% to $6.02 for the Current Session; Price Setup: the Near-Term Reference Band Stretches From $5.72 to $6.32Channel Projection - vinanet.vn
CapsoVision (CV) Market: Ends Higher by 1.86% at $6.02 in the Latest Reading; Current Setup: the Supplied Trading Band Runs From $5.72 to $6.32 at the CloseLow Vol Factor - dars.gov.et
CapsoVision (CV) Market: Ends Higher by 1.86% at $6.02 in the Latest Reading; Current Setup: the Supplied Trading Band Runs From $5.72 to $6.32 at the CloseSmall Cap Breakouts - vinanet.vn
CapsoVision (CV) Market: Ends Higher by 1.86% at $6.02 in the Latest Reading; Current Setup: the Supplied Trading Band Runs From $5.72 to $6.32 at the CloseLate Stage Breakouts - dars.gov.et
CapsoVision (CV) Earnings Update: The Bottom-Line Figure Trails Its Comparison; Latest Reaction: The Stock Ends Down 0.49%Basic EPS Analysis - vinanet.vn
CapsoVision (CV) Earnings Update: The Bottom-Line Figure Trails Its Comparison; Latest Reaction: The Stock Ends Down 0.49%Earnings Turnaround - siam.in
CapsoVision Initiates $100 Million At-the-Market Equity Offering with Cantor Fitzgerald - Kalkine Media
CapsoVision Launches $100 Million At-The-Market Offering - TipRanks
CapsoVision launches $100M at-the-market equity program with Cantor Fitzgerald - TradingView
The CapsoVision, Inc. (NASDAQ:CV) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - 富途牛牛
The CapsoVision, Inc. (NASDAQ:CV) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - Moomoo
CapsoVision Earnings Call: Growth, AI Push, Margin Strain - TipRanks
CapsoVision stock rating maintained at Speculative Buy by Benchmark - Investing.com
CapsoVision stock rating maintained at Speculative Buy by Benchmark - Investing.com Australia
CapsoVision stock rating maintained at Speculative Buy by Benchmark - Investing.com Canada
CapsoVision stock rating maintained at Speculative Buy by Benchmark - Investing.com
CapsoVision (CV) Q2 2026 Earnings Call: Umsatz steigt um 10 %, KI-Einführung schreitet voran - TradingKey
CapsoVision Inc (CV) (Q2 2026) Earnings Call Highlights: AI Launch Drives Growth Amid Pricing ... By GuruFocus - Investing.com Canada
CapsoVision (CV) Stock Rich Valuation Meets Widening Losses - webull.com
CapsoVision Q2 Earnings Call Highlights - MarketBeat
CapsoVision Q2 Earnings Call Highlights - MarketBeat
CapsoVision Q2 Earnings Call Highlights - Yahoo Finance
CAPSOVISION ($CV) Releases Q2 2026 Earnings - Quiver Quantitative
CapsoVision Q2 Results: Revenue rises 10% to $3.6 million - scanx.trade
Earnings call transcript: CapsoVision Q2 2026 loss widens as shares fall after hours - Investing.com
CapsoVision Reports Q2 2026 Financials: Inventory Growth and Balance Sheet Update - Kalkine Media
CapsoVision Files Mixed Shelf for Up to $250 Million in Securities - marketscreener.com
CapsoVision Q2 2026 Earnings Call Transcript - Benzinga
CapsoVision Launches $100 Million At-the-Market Equity Program - TipRanks
CapsovisionMay Offer Up To $250 Million Of Common Stock, Preferred Stock, Warrants, Rights, And Units - TradingView
CapsoVision (CV) widens losses in H1 2026 and flags going concern risk - Stock Titan
CapsoVision, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CapsoVision, Inc. Provides Revenue Guidance for the Second Half of 2026 - marketscreener.com
CapsoVision Reports Second Quarter 2026 Financial Results - Yahoo Finance
CapsoVision Inc (CV) Stock News Today - TradingKey
Top insider buys and sells from Tuesday’s disclosures By Investing.com - Investing.com Nigeria
CV Q1 2026 Earnings: Wider-Than-Expected Loss of $0.15 Per Share, Stock Rises 2.9%Adjusted Earnings Analysis - vinanet.vn
Capsovision Inc Stock (CV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Capsovision Inc Stock (CV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Shen Ching Hang | 10% Owner |
Sep 15 '26 |
Buy |
5.69 |
878,734 |
4,999,996 |
2,926,655 |
| HARARI ELIYAHOU ET AL | 10% Owner |
Jul 17 '26 |
Buy |
6.73 |
61,068 |
410,988 |
3,343,119 |
| HARARI ELIYAHOU ET AL | 10% Owner |
Jul 08 '26 |
Buy |
6.09 |
81,300 |
495,117 |
3,282,051 |
| Kuo Hui Ying | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
15,263 |
| King Wen-Herng Henry | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
25,619 |
| Harari Michele | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
61,065 |
| GOUW JULIA S | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
4,909 |
| Imperial Joanne Carol | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
3,709 |
| Tsai Chen Lung | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
4,929 |
| HARARI ELIYAHOU ET AL | 10% Owner |
Jun 26 '26 |
Buy |
7.35 |
13,850 |
101,811 |
3,200,751 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):